-
861por Mills, Anthony, Priest, Julie, Musallam, Alexander, Althoff, Keri, Eron, Joseph, Huhn, Greg, Jayaweera, Dushyantha, Mounzer, Karam, Moyle, Graeme, Mrus, Joe, Rampogal, Moti, Santiago, Steven, Sax, Paul, Voskuhl, Gene, Oglesby, Alan, Elion, Richard“…Oglesby, ViiV Healthcare: Employee and Shareholder, Salary. R. Elion, Gilead: Investigator, Scientific Advisor and Speaker’s Bureau, Consulting fee, Research support and Speaker honorarium. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
862por Wijs, L A, Doherty, D A, Keelan, J A, Burton, P, Yovich, J L, Beilin, L, Mori, T A, Huang, R C, Adams, L A, Olynyk, J K, Ayonrinde, O T, Penova-Veselinovic, B, Hart, R J“…R.J.H. is the Medical Director of Fertility Specialists of Western Australia and a shareholder in Western IVF. He has received educational sponsorship from MSD, Merck-Serono and Ferring Pharmaceuticals. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
863por Schreiber, S, Bleakman, A P, Dubinsky, M C, Rubin, D, Hibi, T, Panaccione, R, Gibble, T H, Kayhan, C, Flynn, E, Sapin, C, Atkinson, C, Travis, S, Jones, J“…Bleakman Employee of: Eli Lilly and Company, M. Dubinsky Shareholder of: Trellus Health, Grant / Research support from: AbbVie, Janssen, Pfizer, and Prometheus Biosciences, Consultant of: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly and Company, F. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
864por Travis, S, Bleakman, A P, Rubin, D, Dubinsky, M C, Panaccione, R, Hibi, T, Gibble, T H, Kayhan, C, Flynn, E, Sapin, C, Atkinson, C, Schreiber, S, Jones, J“…Rubin Grant / Research support from: Takeda, Consultant of: AbbVie, Allergan, AltruBio, American College of Gastroenterology, Arena Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene/Syneos Health, Cornerstones Health (non-profit), Eli Lilly and Company, Galen/Atlantica, Genentech/Roche, Gilead Sciences, GoDuRn, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen, Materia Prima, Pfizer, Prometheus Therapeutics and Diagnostics, Reistone Biopharma, Takeda, and TechLab, M. Dubinsky Shareholder of: Trellus Health, Grant / Research support from: AbbVie, Janssen, Pfizer, and Prometheus Biosciences, Consultant of: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly and Company, F. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
865por Seidel, Danila, Cornely, Oliver, Vehreschild, Maria J G T, Koehler, Philipp, Salmanton-García, Jon, Klimko, Nikolay, Herbrecht, Raoul, Heinemann, Melina, Prattes, Jürgen, Schalk, Enrico, Miceli, Marisa H, Ráčil, Zdeněk, Falces-Romero, Iker, Hoenigl, Martin, Kessel, Johanna, Bertz, Hartmut, Novak, Jan, Wisplinghoff, Hilmar, Barmaki-Rad, Farima, Saulay, Mikael, Engelhardt, Marc, Hamed, Kamal“…(Board Member, Consultant, Employee, Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member, Research Grant or Support, Shareholder, Speaker’s Bureau, Independent Contractor, Other Financial or Material Support)Basilea Pharmaceutica International Ltd. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
866por Rubinstein, Samuel, Lynch, Ryan C., Desai, Aakash, Stratton, Catherine, Jha, Alokkumar, Bakouny, Ziad, Schmidt, Andrew, Sica, R. Alejandro, Bhutani, Divaya, Shah, Dimpy P., Wall, Sarah A, Lyman, Gary H., Kuderer, Nicole M., Weiss, Matthias, Warner, Jeremy L., Stockerl-Goldstein, Keith E., Mesa, Ruben, Thompson, Michael A.“…Warner:HemOnc.orgLLC: Other: Shareholder/Stockholder/Stock options; National Cancer Institute: Research Funding; IBM Watson Health: Consultancy; Westat: Consultancy. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
867por Sands, B E, Feagan, B, Gibble, T H, Traxler, K A, Morris, N, Li, X, Schreiber, S, Jairath, V, Armuzzi, A, Jones, J“…Sands Consultant of: Abivax, Amgen, Arena Pharmaceuticals, Artugen Therapeutics, AstraZeneca, Bacainn Therapeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Calibr, Celltrion, ClostraBio, Eli Lilly and Company, Enthera, Evommune, Galapagos NV, Genentech, Gilead Sciences, GlaxoSmithKline, Gossamer Bio, InDex Pharmaceuticals, Innovation Pharmaceuticals, Inotrem, Ironwood Pharmaceuticals, Janssen, Kaleido Biosciences, Kallyope, MiroBio, Morphic Therapeutic, MRM Health, Pfizer, Progenity, Prometheus Therapeutics and Diagnostics, Protagonist Therapeutics, Q32 Bio, Surrozen, Takeda, Teva, TLL Pharmaceutical, USWM Enterprises, and Viela Bio, B. Feagan Shareholder of: Gossamer Bio, Consultant of: AbbVie, AdMIRx, AgomAb Therapeutics, Akebia Therapeutics, Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Avir Pharma, Azora Therapeutics, Boehringer Ingelheim, Boston Scientific, Celgene/Bristol Myers Squibb, Connect BioPharma, Cytoki Pharma, Disc Medicine, Ecor1 Capital, Eli Lilly and Company, Equillium, Everest Clinical Research, F. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
868por Clemow, D B, Sapin, C, Hibi, T, Dubinsky, M C, Vermeire, S, Schreiber, S, Gibble, T H, Peyrin-Biroulet, L, Watanabe, M, Panaccione, R, Jones, J“…Hibi Grant / Research support from: AbbVie, ActivAid, Alfresa Pharma, Bristol Myers Squibb, Eli Lilly Japan K.K., Ferring Pharmaceuticals, Gilead Sciences, Janssen Pharmaceutical K.K., JMDC, Mochida Pharmaceutical, Nippon Kayaku, Pfizer Japan, and Takeda, Consultant of: AbbVie, Apo Plus Station, Bristol Myers Squibb, Celltrion, EA Pharma, Eli Lilly and Company, Gilead Sciences, Janssen, Kyorin, Mitsubishi Tanabe Pharma, Nichi-Iko Pharmaceutical, Pfizer, Takeda, and Zeria Pharmaceutical, Speakers bureau of: AbbVie, Aspen Japan K.K., Ferring Pharmaceuticals, Gilead Sciences, Janssen, JIMRO, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Pfizer, and Takeda, M. Dubinsky Shareholder of: Trellus Health, Grant / Research support from: AbbVie, Janssen, Pfizer, and Prometheus Biosciences, Consultant of: AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly and Company, F. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
869por McKinnell, James A, Miller, Loren, Singh, Raveena D, Mendez, Job, Franco, Ryan, Gussin, Gabrielle, Chang, Justin, Dutciuc, Tabitha D, Saavedra, Raheeb, Kleinman, Ken, Peterson, Ellena M, Evans, Kaye D, Heim, Lauren, Miner, Aaron, Estevez, Marlene, Custodio, Harold, Yamaguchi, Stacey, Nguyen, Jenny, Varasteh, Alex, Launer, Bryn, Agrawal, Shalini, Tjoa, Thomas, He, Jiayi, Park, Steven, Tam, Steven, Gohil, Shruti K, Stone, Nimalie D, Steinberg, Karl, Montgomery, Jocelyn, Beecham, Nancy, Huang, Susan S“…McKinnell, Allergan: Research Contractor, Scientific Advisor and Speaker’s Bureau, Consulting fee, Research support and Speaker honorarium; Achaogen: Research Contractor, Scientific Advisor and Shareholder, Research support; Cempra: Research Contractor and Scientific Advisor, Research support; Theravance: Research Contractor, Research support; Science 37: Research Contractor, Salary; Expert Stewardship, LLC: Board Member and Employee, Salary; Thermo Fisher: Scientific Advisor, Salary; 3M: Receipt of contributed product, Conducting studies in healthcare facilities that are receiving contributed product; Clorox: Receipt of contributed product, Conducting studies in healthcare facilities that are receiving contributed product; Sage Products: Receipt of contributed product, Conducting studies in healthcare facilities that are receiving contributed product; Xttrium Laboratories: Receipt of contributed product, Conducting studies in healthcare facilities that are receiving contributed product; L. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
870por Li, Ang, Kuderer, Nicole M., Warner, Jeremy L., Desai, Aakash, Shah, Dimpy P., Fu, Julie, Li, Monica, Zon, Rebecca, Shah, Surbhi, Gulati, Shuchi, Khaki, Ali Raza, Kulkarni, Amit, Elshoury, Amro, Thompson, Michael A., Grivas, Petros, de Lima Lopes, Gilberto, Shyr, Yu, Pennell, Nathan A, Schmidt, Andrew, Friese, Christopher R, Stover, Daniel, Patel, Jaymin, Halmos, Balazs, Choueiri, Toni K., Peters, Solange, Rivera, Donna R., Painter, Corrie, Rini, Brian, Lyman, Gary H., Connors, Jean M., Rosovsky, Rachel P.“…Warner:HemOnc.orgLLC: Other: Shareholder/Stockholder/Stock options; IBM Watson Health: Consultancy; Westat: Consultancy; National Cancer Institute: Research Funding. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
871“…Given the influence of controlling shareholders on the company, it is important to analyze how independent directors can protect minority shareholders’ interests using the information and resources obtained from social networks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
872por Lee, Munjae“…CONCLUSION: The higher the shareholding ratio of the major shareholders, the greater the R&D investment. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
873“…Thus, the findings of this study propose changes in the legal framework that would empower institutional investors, primarily by reducing the expropriation of minority shareholders by majority shareholders (concentrated promoters), who could otherwise skew voting outcomes in favor of minority shareholders. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
874“…Further research finds that QFII shareholding has a positive impact on corporate efficiency by improving the level of corporate innovation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
875por Toumi, Amina, Najaf, Khakan, Dhiaf, Mohamed M., Li, Ng Shir, Kanagasabapathy, Shenba“…The findings of this study are essential for policymakers, start-up entrepreneurs, and shareholders.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
876Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises“…Our findings reveal that state capital involvement may encourage private enterprises to disclose environmental information through resource allocation and governance improvements. The higher the shareholding ratio of state-owned participating shareholders, the more it helps private firms to disclose environmental information. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
877“…This paper enriches the impact of institutional investors’ shareholding on corporate ESG disclosure from a heterogeneity perspective.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
878por Roller, Slavek“…Patients-consumers and investors-shareholders have traditionally been viewed as two distinct groups with conflicting interests: shareholders seek maximum profits, patients - maximum clinical benefit. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
879“…Share pledging has become popular as a method of loan collateral among Chinese shareholders. Our research used a sample of Chinese listed firms between 2008–2018 and produced two main findings. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
880“…The risk of a pandemic was well-known before the recent crisis, and we now know that the initial impact on many shareholders was significant and negative. To what extent did managers forewarn their shareholders about this valuation risk? …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto